These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 34081995)

  • 1. Low dose shikonin and anthracyclines coloaded liposomes induce robust immunogenetic cell death for synergistic chemo-immunotherapy.
    Li J; Zhou S; Yu J; Cai W; Yang Y; Kuang X; Liu H; He Z; Wang Y
    J Control Release; 2021 Jul; 335():306-319. PubMed ID: 34081995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fe
    Xue P; Li J; Song J; Yu J; Liu H; Jiang Y; Wang Y
    Int J Pharm; 2024 Jan; 649():123657. PubMed ID: 38040398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Liposomal Co-delivery of an Immunogenic Cell Death Inducer and a Toll-Like Receptor 4 Agonist for Enhanced Cancer Chemo-immunotherapy.
    Park H; Lee S; Son MK; Kang I; Surwase SS; Song YG; Lee HK; Lee YK; Kim YC
    ACS Appl Mater Interfaces; 2024 Aug; 16(32):41810-41818. PubMed ID: 39084852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway.
    Lu J; Liu X; Liao YP; Wang X; Ahmed A; Jiang W; Ji Y; Meng H; Nel AE
    ACS Nano; 2018 Nov; 12(11):11041-11061. PubMed ID: 30481959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Charge reversal yolk-shell liposome co-loaded JQ1 and doxorubicin with high drug loading and optimal ratio for synergistically enhanced tumor chemo-immunotherapy via blockade PD-L1 pathway.
    Liu D; Li K; Gong L; Fu L; Yang D
    Int J Pharm; 2023 Mar; 635():122728. PubMed ID: 36796659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomal Delivery of Mitoxantrone and a Cholesteryl Indoximod Prodrug Provides Effective Chemo-immunotherapy in Multiple Solid Tumors.
    Mei KC; Liao YP; Jiang J; Chiang M; Khazaieli M; Liu X; Wang X; Liu Q; Chang CH; Zhang X; Li J; Ji Y; Melano B; Telesca D; Xia T; Meng H; Nel AE
    ACS Nano; 2020 Oct; 14(10):13343-13366. PubMed ID: 32940463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-Delivery Nanobooster to Enhance Immunogenic Cell Death for Cancer Chemoimmunotherapy.
    Yan C; Zhao Y; Liu X; Jiang Y; Li Q; Yang L; Li X; Luo K
    ACS Appl Mater Interfaces; 2024 Jul; 16(26):33169-33181. PubMed ID: 38915234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repolarizing Tumor-Associated Macrophages and inducing immunogenic cell Death: A targeted liposomal strategy to boost cancer immunotherapy.
    Li C; Wang L; Li Z; Li Z; Zhang K; Cao L; Wang Z; Shen C; Chen L
    Int J Pharm; 2024 Feb; 651():123729. PubMed ID: 38142016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fe(III)-Shikonin supramolecular nanomedicines as immunogenic cell death stimulants and multifunctional immunoadjuvants for tumor vaccination.
    Feng W; Shi W; Cui Y; Xu J; Liu S; Gao H; Zhu S; Liu Y; Zhang H
    Theranostics; 2023; 13(15):5266-5289. PubMed ID: 37908730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of focal adhesion kinase enhances the immunogenic cell death of PEGylated liposome doxorubicin to optimize therapeutic responses of immune checkpoint blockade.
    Zhang B; Li N; Gao J; Zhao Y; Jiang J; Xie S; Zhang C; Zhang Q; Liu L; Wang Z; Ji D; Wu L; Ren R
    J Exp Clin Cancer Res; 2024 Feb; 43(1):51. PubMed ID: 38373953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crizotinib prodrug micelles co-delivered doxorubicin for synergistic immunogenic cell death induction on breast cancer chemo-immunotherapy.
    Liang Q; Lan Y; Li Y; Cao Y; Li J; Liu Y
    Eur J Pharm Biopharm; 2022 Aug; 177():260-272. PubMed ID: 35863668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redox-Activated Porphyrin-Based Liposome Remote-Loaded with Indoleamine 2,3-Dioxygenase (IDO) Inhibitor for Synergistic Photoimmunotherapy through Induction of Immunogenic Cell Death and Blockage of IDO Pathway.
    Liu D; Chen B; Mo Y; Wang Z; Qi T; Zhang Q; Wang Y
    Nano Lett; 2019 Oct; 19(10):6964-6976. PubMed ID: 31518149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Dual-Targeting Liposome Enhances Triple-Negative Breast Cancer Chemoimmunotherapy through Inducing Immunogenic Cell Death and Inhibiting STAT3 Activation.
    Luo K; Yang L; Yan C; Zhao Y; Li Q; Liu X; Xie L; Sun Q; Li X
    Small; 2023 Oct; 19(40):e2302834. PubMed ID: 37264710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autophagy inhibition recovers deficient ICD-based cancer immunotherapy.
    Li J; Cai W; Yu J; Zhou S; Li X; He Z; Ouyang D; Liu H; Wang Y
    Biomaterials; 2022 Aug; 287():121651. PubMed ID: 35777331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifunctional Liposomes Remodeling Tumor Immune Microenvironment for Tumor Chemoimmunotherapy.
    Li X; Luo Y; Huang Z; Wang Y; Wu J; Zhou S
    Small Methods; 2023 May; 7(5):e2201327. PubMed ID: 37075716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced Immunogenic Cell Death and Antigen Presentation
    He T; Wang L; Gou S; Lu L; Liu G; Wang K; Yang Y; Duan Q; Geng W; Zhao P; Luo Z; Cai K
    ACS Nano; 2023 Jun; 17(11):9953-9971. PubMed ID: 37212750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sterically stabilized liposomes as a potent carrier for shikonin.
    Kontogiannopoulos KN; Tsermentseli SK; Assimopoulou AN; Papageorgiou VP
    J Liposome Res; 2014 Sep; 24(3):230-40. PubMed ID: 24597496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ratiometric co-delivery of doxorubicin and paclitaxel prodrug by remote-loading liposomes for the treatment of triple-negative breast cancer.
    Wang Y; Chen L; Zhang Z; Liu W; Li L
    Drug Deliv Transl Res; 2022 Oct; 12(10):2537-2549. PubMed ID: 35043372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor microenvironment-responsive spherical nucleic acid nanoparticles for enhanced chemo-immunotherapy.
    Ma B; Ma Y; Deng B; Xiao P; Huang P; Wang D; Liu L
    J Nanobiotechnology; 2023 May; 21(1):171. PubMed ID: 37237292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-penetrating corosolic acid liposome as a functional carrier for delivering chemotherapeutic drugs.
    Li X; Widjaya AS; Liu J; Liu X; Long Z; Jiang Y
    Acta Biomater; 2020 Apr; 106():301-313. PubMed ID: 32081779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.